Marche Polytechnic University or Polytechnic University of the Marches is a public university in Ancona, Italy. It offers undergraduate and graduate degrees in Agriculture, Engineering, Economics, Medicine and Biology.

During the past decade, Università Politecnica delle Marche conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Università Politecnica delle Marche" #1 sponsor was "Università Politecnica delle Marche" with 4 trials, followed by "Azienda Ospedaliera Cardinale G. Panico" with 1 trials sponsored, "Azienda Ospedaliera Universitaria Policlinico" with 1 trials sponsored, "Camlin Ltd" with 1 trials sponsored and "Gruppo Oncologico del Nord-Ovest" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università Politecnica delle Marche" #1 collaborator was "Università Politecnica delle Marche" with 2 trials as a collaborator, "Azienda Ospedaliera Ospedali Riuniti Marche Nord" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Università Politecnica delle Marche" are "Alzheimer Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Bacteremia" (1 trials), "Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Università Politecnica delle Marche" in a lesser frequency.

Most popular intervention types in "Università Politecnica delle Marche" are "Drug" (6 trials), "Device" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARC intellicare" (1 trials), "Imatinib" (1 trials), "N-acetylcysteine (NAC)" (1 trials), "Overall and 30-day mortality in bad first antibiotic therapy" (1 trials) and "Platelet Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Università Politecnica delle Marche" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Università Politecnica delle Marche". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Università Politecnica delle Marche, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Università Politecnica delle Marche, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Università Politecnica delle Marche has several departments that took part in Clinical trials: "Sezione di Neurologia - Dipartimento di Neuroscienze" - 2 trials